Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection-Reference-Cited by-同舟云学术

Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection

Published:2023-11 Issue:5 Volume:84 Page:473-483
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Meeks Joshua J.,Black Peter C.,Galsky Matthew,Grivas Petros,Hahn Noah M.,Hussain Syed A.,Milowsky Matthew I.,Steinberg Gary D.,Svatek Robert S.,Rosenberg Jonathan E.

Publisher

Elsevier BV

Subject

Urology

Reference43 articles.

1. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer;Powles;Nature,2014

2. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells;Mariathasan;Nature,2018

3. The 2021 updated European Association of Urology guidelines on metastatic urothelial carcinoma;Cathomas;Eur Urol,2022

4. Systematic review of immune checkpoint inhibition in urological cancers;Rijnders;Eur Urol,2017

5. Adjuvant immune checkpoint inhibition in muscle-invasive bladder cancer: is it ready for prime time?;Kartolo;Eur Urol,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative Review;Cancers;2024-09-01

2. The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis;Cancer Treatment Reviews;2024-09

3. Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer;European Urology;2024-09

4. Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study;Scientific Reports;2024-08-27

5. Trends in research on nanomedicine in urologic cancer: a bibliometric and visualized analysis;Discover Oncology;2024-08-23